Search research articles
Contact Us
Filters
Showing results (91-100 of 721) with videos related to
Page
of 73
Sort By:
European Urology
|
January 24, 2017
A PET for All Seasons: <sup>18</sup>F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?
Wolfgang P Fendler, Matthias Eiber, Christian G Stief, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2025
Treatment Landscape of Prostate Cancer in the Era of PSMA Radiopharmaceutical Therapy
Fabio Turco, Silke Gillessen, Ken Herrmann, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
May 21, 2026
FDG PET Hybrid Imaging
Caner Civan, Wolfgang P Fendler, Bernd J Krause, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 26, 2017
Therapy assessment in prostate cancer using choline and PSMA PET/CT
Francesco Ceci, Ken Herrmann, Boris Hadaschik, et al.
European Urology
|
October 20, 2024
Prostate-specific Membrane Antigen (PSMA) Spatial Biomarker: Standardized Positron Emission Tomography Disease Maps Provide Accurate Prediction of Overall Survival in Prostate Cancer
Wolfgang P Fendler, Viktor Grünwald, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 16, 2024
[<sup>177</sup>Lu]Lu-DOTATATE May Resensitize Neuroendocrine Tumors to Hormonal Therapy: Initial Clinical Experience in Renal Carcinoid
Akram Al-Ibraheem, Ahmed Abdlkadir, Dhuha Al-Adhami, et al.
Nature Reviews. Clinical Oncology
|
September 9, 2025
The molecular blueprint of targeted radionuclide therapy
Irina Primac, Kevin Tabury, Alpaslan Tasdogan, et al.
European Urology Open Science
|
August 31, 2022
Virtual Prostate Biopsy with Prostate-specific Membrane Antigen and Magnetic Resonance Imaging: Closer to Reality in a Subgroup of Prostate Cancer Patients?
Kelsey L Pomykala, Ken Herrmann, Louise Emmett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 22, 2009
18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer
Bernd Joachim Krause, Ken Herrmann, Hinrich Wieder, et al.
Clinical Nuclear Medicine
|
October 25, 2013
Primary central nervous system lymphoma and meningioma in DOTATATE PET/CT
Constantin Lapa, Mario Löhr, Christina Bluemel, et al.
Page
of 73
Search research articles
Search
Showing results (91-100 of 721) with videos related to
Sort By:
Page
of 73
European Urology
|
January 24, 2017
A PET for All Seasons: <sup>18</sup>F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?
Wolfgang P Fendler, Matthias Eiber, Christian G Stief, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2025
Treatment Landscape of Prostate Cancer in the Era of PSMA Radiopharmaceutical Therapy
Fabio Turco, Silke Gillessen, Ken Herrmann, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
May 21, 2026
FDG PET Hybrid Imaging
Caner Civan, Wolfgang P Fendler, Bernd J Krause, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 26, 2017
Therapy assessment in prostate cancer using choline and PSMA PET/CT
Francesco Ceci, Ken Herrmann, Boris Hadaschik, et al.
European Urology
|
October 20, 2024
Prostate-specific Membrane Antigen (PSMA) Spatial Biomarker: Standardized Positron Emission Tomography Disease Maps Provide Accurate Prediction of Overall Survival in Prostate Cancer
Wolfgang P Fendler, Viktor Grünwald, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 16, 2024
[<sup>177</sup>Lu]Lu-DOTATATE May Resensitize Neuroendocrine Tumors to Hormonal Therapy: Initial Clinical Experience in Renal Carcinoid
Akram Al-Ibraheem, Ahmed Abdlkadir, Dhuha Al-Adhami, et al.
Nature Reviews. Clinical Oncology
|
September 9, 2025
The molecular blueprint of targeted radionuclide therapy
Irina Primac, Kevin Tabury, Alpaslan Tasdogan, et al.
European Urology Open Science
|
August 31, 2022
Virtual Prostate Biopsy with Prostate-specific Membrane Antigen and Magnetic Resonance Imaging: Closer to Reality in a Subgroup of Prostate Cancer Patients?
Kelsey L Pomykala, Ken Herrmann, Louise Emmett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 22, 2009
18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer
Bernd Joachim Krause, Ken Herrmann, Hinrich Wieder, et al.
Clinical Nuclear Medicine
|
October 25, 2013
Primary central nervous system lymphoma and meningioma in DOTATATE PET/CT
Constantin Lapa, Mario Löhr, Christina Bluemel, et al.
Page
of 73